UnitedHealth Group (UNH) Stock Forecast & Price Target

$584.21

+0.65 (+0.11%)

(As of 09:47 AM ET)

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 20 Analyst Ratings

Sell
0

Hold
1

Buy
19

Based on 20 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 20 analysts, 1 has given a hold rating, 18 have given a buy rating, and 1 has given a strong buy rating for UNH.

Consensus Price Target

$614.17
5.24% Upside

According to the 20 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $614.17. The highest price target for UNH is $680.00, while the lowest price target for UNH is $559.00. The average price target represents a forecasted upside of 5.24% from the current price of $584.21.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

UNH Analyst Ratings Over Time

Type	Current Forecast 10/9/23 to 10/8/24	1 Month Ago 9/9/23 to 9/8/24	3 Months Ago 7/11/23 to 7/10/24	1 Year Ago 10/9/22 to 10/9/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	18 Buy rating(s)	18 Buy rating(s)	17 Buy rating(s)	13 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$614.17	$614.17	$579.74	$573.52
Forecasted Upside	5.24% Upside	2.90% Upside	15.73% Upside	8.90% Upside
Consensus Rating	Buy	Buy	Moderate Buy	Moderate Buy

The most important AI company you've never heard of (Ad)

Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.

Get the full story on this secret AI company poised for massive growth

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.78	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	5.24% Upside	10,674.30% Upside	8.03% Upside
News Sentiment Rating	Positive News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/1/2024	Cantor Fitzgerald 3 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$591.00 ➝ $591.00	+0.62%
7/18/2024	HSBC 2 of 5 stars		Boost Target		$580.00 ➝ $610.00	+7.68%
7/18/2024	UBS Group 4 of 5 stars		Boost Target	Buy ➝ Buy	$640.00 ➝ $680.00	+20.90%
7/17/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$570.00 ➝ $600.00	+4.95%
7/17/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$546.00 ➝ $601.00	+5.51%
7/17/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$560.00 ➝ $604.00	+6.30%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
7/17/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$525.00 ➝ $630.00	+11.23%
7/17/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$555.00 ➝ $615.00	+8.86%
7/17/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$595.00 ➝ $615.00	+12.05%
7/17/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$597.00 ➝ $640.00	+16.60%
7/17/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$600.00 ➝ $640.00	+16.60%
7/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$481.00 ➝ $647.00	+17.88%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$546.00 ➝ $559.00	+15.75%
4/19/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$545.00 ➝ $562.00	+13.96%
4/17/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$566.00 ➝ $571.00	+18.76%
3/13/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
3/7/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$675.00	+42.83%
2/8/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$605.00	+16.37%
1/17/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$610.00	+15.23%
7/18/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$595.00 ➝ $603.00	+24.55%
7/11/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$600.00 ➝ $549.00	+18.56%
6/14/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$625.00 ➝ $560.00	+13.98%
4/17/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$590.00 ➝ $600.00	+17.24%
4/14/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Strong-Buy	$630.00	+24.75%
12/7/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$590.00 ➝ $610.00	+13.11%
10/17/2022	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$625.00 ➝ $618.00	+20.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:11 AM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, October 6, 2024. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

UnitedHealth Group has shown consistent growth in institutional investments, indicating confidence from large investors in the company's future prospects.
Recent insider trading activities suggest that company insiders are holding a significant portion of the stock, aligning their interests with shareholders.
UnitedHealth Group operates in a diversified health care sector through various segments, providing stability and resilience against market fluctuations.
The company's stock price has been relatively stable, offering a potential opportunity for steady long-term growth.
UnitedHealth Group's strong financial position and market presence make it a reliable choice for investors seeking stability and consistent returns.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

Despite institutional ownership, the company's stock may be subject to market volatility, impacting short-term investment strategies.
Recent hedge fund activities show mixed sentiments towards UnitedHealth Group, indicating potential uncertainty among some institutional investors.
UnitedHealth Group's dependency on the healthcare industry's regulatory environment could pose risks related to policy changes and government interventions.
Investors should consider the competitive landscape within the health care sector, as increased competition may affect UnitedHealth Group's market share and profitability.
Fluctuations in health care spending trends and reimbursement policies could impact UnitedHealth Group's financial performance and stock valuation.

UNH Forecast - Frequently Asked Questions

: According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $614.17, with a high forecast of $680.00 and a low forecast of $559.00.
: 20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last twelve months. There is currently 1 hold rating, 18 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" UNH shares.
: According to analysts, UnitedHealth Group's stock has a predicted upside of 5.13% based on their 12-month stock forecasts.
: Over the previous 90 days, UnitedHealth Group's stock had 1 upgrade by analysts.
: UnitedHealth Group has been rated by research analysts at Argus, Barclays, Cantor Fitzgerald, HSBC, Jefferies Financial Group, Morgan Stanley, Robert W. Baird, Royal Bank of Canada, TD Cowen, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating for UnitedHealth Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks (Ad)

Usually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...

Click here now to claim your FREE copy of Marc's AI playbook.

This page (NYSE:UNH) was last updated on 10/8/2024 by MarketBeat.com Staff

From Our Partners